Linden Advisors’s The Oncology Institute Warrant TOIIW Stock Holding History
Bought
Maintained
Sold
Other funds holding TOIIW
DM
UOC
RCM
DKCM
KC
QGA
GCL
Linden Advisors's TOIIW Position: Q2 2021 in Review
Linden Advisors sold out of The Oncology Institute Warrant (TOIIW) in Q2 2021, closing a stake of 24,316 shares — an estimated $35K sold.
Linden Advisors first reported a position in TOIIW in Q2 2020 and held it in 4 quarters. The position peaked at $53K in Q3 2020. 26 funds tracked by Wall St. Rank hold TOIIW as of Q2 2021.
- Linden Advisors reported no remaining The Oncology Institute Warrant position as of Q2 2021 after selling out during the quarter.
- Linden Advisors sold 24,316 The Oncology Institute Warrant shares in Q2 2021, an estimated $35K.
- Linden Advisors first reported a position in The Oncology Institute Warrant in Q2 2020 and held it in 4 quarters.
- Linden Advisors's The Oncology Institute Warrant position peaked at $53K in Q3 2020.
- 26 funds tracked by Wall St. Rank held The Oncology Institute Warrant as of Q2 2021.
Based on Linden Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.